Engineering services company L&T Technology Services Limited (NSE: LTTS) announced on Monday that it has partnered with AI computing company NVIDIA to unveil Gen AI and advanced software-defined architecture for medical devices, focusing on endoscopy. The collaborative effort aims to address industry challenges related to custom hardware components, enhancing image quality and scalability for medical applications.
The scalable platform integrates a comprehensive image processing pipeline, incorporating noise reduction, edge and contrast enhancement, texture and color enhancement and speckle correction. Unique features include AI/ML models for polyp detection during colonoscopies.
Leveraging NVIDIA Holoscan and NVIDIA IGX Orin platforms, the architecture ensures low-latency data transfer, superior image processing and scalability for multiple AI-enabled applications, enhancing visualisation and decision-making support.
L&T Technology Services, a subsidiary of Larsen & Toubro Limited, specializes in Engineering and R&D services, serving Fortune 500 and top ER&D companies globally across various industries. With over 23,800 employees and a vast global presence, the collaboration emphasizes cutting-edge advancements in medical imaging technology.
Perrigo to acquire United States rights for Entocort from AstraZeneca
US FDA approves Boehringer Ingelheim's Pradaxa
Phase II clinical trial for potential treatment of androgenetic alopecia completed by Samumed
Life Sciences Partners collaborates on immuno-oncology with Bristol-Myers Squibb
Arsanis initiates first cohort in Phase one clinical trial of ASN100
Impax introduces generic Avodart (Dutasteride) Capsules, 0.5 mg
Mylan unveils generic FazaClo orally disintegrating tablets for treating schizophrenia